Efficacy of Acupuncture Treatment to Prevent Cerebral Vasospasm After Subarachnoid Hemorrhage: A Double-Blind, Randomized Placebo-Controlled Trial

被引:9
|
作者
Lee, Dong-Hyuk [1 ]
Cho, Seung-Yeon [1 ,2 ]
Yang, Seung-Bo [1 ,2 ]
Lee, Hyoung-Min [3 ]
Shin, Hee Sup [2 ,4 ]
Lee, Seung Hwan [2 ,4 ]
Koh, Jun Seok [2 ,4 ]
Kwon, Seungwon [1 ]
Jung, Woo-Sang [1 ]
Moon, Sang-Kwan [1 ]
Park, Jung-Mi [1 ,2 ]
Ko, Chang-Nam [1 ,2 ]
Kim, Ho [5 ,6 ]
Park, Seong-Uk [1 ,2 ]
机构
[1] Kyung Hee Univ, Dept Cardiol & Neurol, Coll Korean Med, Seoul, South Korea
[2] Kyung Hee Univ Hosp Gangdong, Stroke & Neurol Disorders Ctr, 892 Dongnam Ro, Seoul 05278, South Korea
[3] Kyung Hee Univ, Grad Sch, Dept Clin Korean Med, Seoul, South Korea
[4] Kyung Hee Univ, Sch Med, Dept Neurosurg, Seoul, South Korea
[5] Seoul Natl Univ, Dept Epidemiol & Biostat, Grad Sch Publ Hlth, Seoul, South Korea
[6] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea
关键词
cerebral vasospasm; delayed ischemic neurologic deficit (DIND); SAH; acupuncture; electroacupuncture; NITRIC-OXIDE; PLASMA ENDOTHELIN; ELECTROACUPUNCTURE; HYPERTENSION; MECHANISMS; STROKE;
D O I
10.1089/acm.2020.0156
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objectives:To investigate the efficacy of acupuncture in preventing cerebral vasospasm following aneurysmal subarachnoid hemorrhage (SAH) and explore its underlying mechanism. Design:A randomized, double-blinded, and placebo-controlled trial. Setting/Location:Subjects were recruited from Kyung Hee University Hospital at Gangdong, Seoul, Korea Subjects:A total of 50 patients admitted with acute SAH. Interventions:The study group received acupuncture treatments (n = 25), while the control group underwent mock transcutaneous electrical nerve stimulation and sham acupuncture (n = 25) six times/week for 2 weeks. Outcome measures:The primary outcome was the incidence of delayed ischemic neurologic deficit (DIND), and secondary measurements included angiographic vasospasm, vasospasm-related infarction, modified Rankin Scale score, and plasma nitric oxide (NO) and endothelin-1 (ET-1) levels. Results:The study group treated with acupuncture showed a lower incidence of DIND (9.1%) than the control group (20.8%); however, this difference in the incidence of DIND was not statistically significant. The study group demonstrated better clinical outcomes, especially in functional recovery. Significant alterations in plasma NO and ET-1 levels after the 2-week intervention were observed only in the study group. Conclusions:Their study shows that acupuncture treatment improved functional recovery after SAH and could potentially prevent cerebral vasospasm. These effects could be attributed to the recovery of endothelial dysfunction by acupuncture through modulating the plasma NO and ET-1 levels. The study protocol has been registered onwww.clinicaltrials.gov(NCT02275949).
引用
收藏
页码:1182 / 1189
页数:8
相关论文
共 50 条
  • [21] The Efficacy of Diacerein in Hand Osteoarthritis: A Double-Blind, Randomized, Placebo-Controlled Study
    Shin, Kichul
    Kim, Joon Wan
    Moon, Ki Won
    Yang, Ji Ae
    Lee, Eun Yeong
    Song, Yeong Wook
    Lee, Eun Bong
    CLINICAL THERAPEUTICS, 2013, 35 (04) : 431 - 439
  • [22] Extended-Release Carvedilol in the Treatment of Hypertension: A Double-Blind, Randomized, Placebo-Controlled Trial
    Wang, Kang-Ling
    Fang, Chih-Yuan
    Lai, Wen-Ter
    Wang, Tzung-Dau
    Ueng, Kwo-Chang
    Wang, Kuo-Yang
    Wang, Ji-Hung
    Shyu, Kou-Gi
    Chiang, Chern-En
    ACTA CARDIOLOGICA SINICA, 2021, 37 (02) : 186 - 194
  • [23] Efficacy of Huoxue Qianyang Qutan Recipe on essential hypertension: A randomized, double-blind, placebo-controlled trial
    Xie, Jun
    Ma, Yu-long
    Gui, Ming-tai
    Yao, Lei
    Li, Jian-hua
    Wang, Ming-zhu
    Zhou, Xun-jie
    Wang, Yi-fan
    Zhao, Ming-yi
    Cao, Hui
    Lu, Bo
    Fu, De-yu
    JOURNAL OF INTEGRATIVE MEDICINE-JIM, 2024, 22 (04): : 484 - 492
  • [24] Zinc supplementation in prediabetes: A randomized double-blind placebo-controlled clinical trial
    Ranasinghe, Priyanga
    Wathurapatha, Wasundara S.
    Galappatthy, Priyadarshani
    Katulanda, Prasad
    Jayawardena, Ranil
    Constantine, Godwin R.
    JOURNAL OF DIABETES, 2018, 10 (05) : 386 - 397
  • [25] Immunomodulatory Effects of Saffron: A Randomized Double-Blind Placebo-Controlled Clinical Trial
    Kianbakht, S.
    Ghazavi, A.
    PHYTOTHERAPY RESEARCH, 2011, 25 (12) : 1801 - 1805
  • [26] Acupuncture-ameliorated menopausal symptoms: single-blind, placebo-controlled, randomized trial
    Castelo Branco de Luca, A.
    Maggio da Fonseca, A.
    Carvalho Lopes, C. M.
    Bagnoli, V. R.
    Soares, J. M., Jr.
    Baracat, E. C.
    CLIMACTERIC, 2011, 14 (01) : 140 - 145
  • [27] Acupuncture for nasal congestion: A prospective, randomized, double-blind, placebo-controlled clinical pilot study
    Sertel, Serkan
    Bergmann, Zazie
    Ratzlaff, Kerstin
    Baumann, Ingo
    Greten, Henry Johannes
    Plinkert, Peter Karl
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2009, 23 (06) : E23 - E28
  • [28] Inhaled Nitric Oxide in Fibrotic Lung Disease A Randomized, Double-Blind, Placebo-controlled Trial
    Nathan, Steven D.
    Rajicic, Natasa
    Dudenhofer, Rosemarie
    Hussain, Rahat
    Argula, Rahul
    Bandyopadhyay, Debabrata
    Luckhardt, Tracy
    Muehlemann, Natalia
    Flaherty, Kevin R.
    Glassberg, Marilyn K.
    Lancaster, Lisa
    Raghu, Ganesh
    Fernandes, Peter
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2024, 21 (12) : 1661 - 1669
  • [29] Acupuncture for reducing pruritus induced by intrathecal morphine at elective cesarean delivery: a placebo-controlled, randomized, double-blind trial
    Mazda, Y.
    Kikuchi, T.
    Yoshimatsu, A.
    Kato, A.
    Nagashima, S.
    Terui, K.
    INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA, 2018, 36 : 66 - 76
  • [30] Impact of Octreotide on Early Complications After Liver Transplant: A Randomized, Double-Blind Placebo-Controlled Trial
    Lankarani, Kamran Bagheri
    Safa, Hoda
    Ghahramani, Sulmaz
    Sayari, Mohammad
    Malekhosseini, Seyed-Ali
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2022, 20 (09) : 835 - 841